Organization
Shanghai Jiao Tong University School of Medicine
46 clinical trials
6 abstracts
Clinical trial
A Double-blind, Randomized Controlled Study of Finerenone vs. Spironolactone in Hypertensive Patients With Primary AldosteronismStatus: Not yet recruiting, Estimated PCD: 2024-12-16
Abstract
Perioperative fuzuloparib plus mFOLFIRINOX for resectable pancreatic adenocarcinoma: A phase 1 study.Org: Pancreatic Disease Center, Shanghai Jiao Tong University School of Medicine,
Clinical trial
Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma: A Single-arm Phase I TrialStatus: Completed, Estimated PCD: 2020-11-02
Abstract
MEK inhibitor combined with RTK inhibitor (trametinib plus anlotinib) in non-G12C KRAS-mutant non-small cell lung cancer: A new strategy.Org: Shanghai Chest Hospital, Jiaotong University, Shanghai Jiao Tong University School of Medicine,
Abstract
A propensity score–matched comparison of fruquintinib (FRU) versus FRU combined with PD-1 inhibitors for microsatellite stability (MSS) metastatic colorectal cancer: Real-world data.Org: Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital Shanghai Jiaotong University School of Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Gracell Biotechnologies, Ltd.,
Abstract
Trophoblast cell-surface antigen 2 is a biomarker and potential therapeutic target in human colon cancer.Org: Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital Shanghai Jiaotong University School of Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Gracell Biotechnologies, Ltd.,
Clinical trial
Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)Status: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Rifabutin-containing Triple Therapy for Helicobacter Pylori Rescue Treatment: a Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-11-30
Clinical trial
Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients: A Single-arm Phase I TrialStatus: Completed, Estimated PCD: 2021-04-12
Clinical trial
Neoadjuvant Toripalimab and Albumin Paclitaxel /Cisplatin Versus Docetaxel/ Cisplatin/ 5-fluorouracil (TPF) on Pathological Response in Patients With Locally Advanced and Resectable Oral Squamous Cell CarcinomaStatus: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
Randomized and Controlled Clinical Study of High-dose Dual Therapy With Different Administration Frequencies in the Treatment of Helicobacter PyloriStatus: Completed, Estimated PCD: 2023-09-10
Clinical trial
RCT Study of Liuwei Dihuang Pill Preventing and Treating Presbycusis With Shen (Kidney)-Yin DeficiencyStatus: Recruiting, Estimated PCD: 2024-05-30
Clinical trial
Multiple-center Randomized Study to Compare Fludarabine and Busulfan Versus Fludarabine, Busulfan and Melphalan in Adult Patients With Acute Myeloid Leukemia (AML) and Myelodysplasia Syndrome (MDS)Status: Recruiting, Estimated PCD: 2025-10-30
Clinical trial
A Randomized Phase II Trial of TPF Induction Chemotherapy in cN2 Patients With Oral Squamous Cell CarcinomaStatus: Terminated, Estimated PCD: 2023-07-30
Clinical trial
Augmented Reality Serious Game Design for Promoting Children's Science Education Cognition: a Randomized Controlled TrialStatus: Completed, Estimated PCD: 2022-07-01
Clinical trial
Cladribine With Intermediate Cytarabine, G-CSF and VP16 Sequential With Fludarabine and Busulifan as Condoning Regimen for Refractory Acute LeukemiaStatus: Completed, Estimated PCD: 2021-08-30
Clinical trial
A Multiple-center Phase II Study to Evaluate the Clinical Outcome of Reduced Conditioning Regimen With Melphalan, Busulfan and Fludarabine for Patients >=55 Years With Myeloid Malignancies.Status: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Multi-center Phase II Prospective Study for the Treatment of Chidamide and Venetoclax in Patients With All-trans Retinoic Acid (ATRA) and Arsenic (As) Resistant Acute Promyelocytic Leukemia (APL)Status: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Phase II Clinical Trial of Flu-Bu-Mel-E (Fludarabine, Busulfan, Melphalan and Etoposide) as Conditioning Regimen for Patients With Lymphoid Malignancies Undergoing Allogeneic Stem Cell TransplantationStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
The Effect of Omega-3 Fatty Acids on Hypertriglyceridemia in Patients With Type 2 Diabetes MellitusStatus: Completed, Estimated PCD: 2021-03-01
Clinical trial
A Phase II Single Arm Study of Cladribine, Cytarabine, Etoposide and Venetoclax Sequential With Reduced Dose Conditioning of Fludarabine, Busulfan and Melphalan or Total Marrow Radiation for Refractory Acute Myeloid LeukemiaStatus: Recruiting, Estimated PCD: 2026-02-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial to Evaluate the Effect of Akkermansia Muciniphila WST01 Strain in Patients With Type 2 DiabetesStatus: Active (not recruiting), Estimated PCD: 2022-11-09
Clinical trial
A Comparison Study of Reduced Dose of Post-transplantation Cyclophosphamide (PTCy 40mg/kg) Versus Standard (PTCY 50mg/kg): a Multi-center Study for Halo-identical Donor TransplantationStatus: Not yet recruiting, Estimated PCD: 2025-10-01
Clinical trial
Evaluation of the Efficacy and Safety of Autologous Transplantation of Expanded Pancreatic Islet Cells (YD01-2022) in Patients With Diabetes Mellitus After Total PancreatectomyStatus: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
Neoadjuvant Personalized Anti-PD-1 Therapy With Combination of Anti-VEGFR Therapy in Locally Advanced and Resectable Oral Squamous Cell Carcinoma: A Randomized Controlled Phase II TrialStatus: Recruiting, Estimated PCD: 2024-08-30
Clinical trial
A Multi-Center and Randomized Control Trial of Cisplatin, Carboplatin, Oxaliplatin, Docetaxel and Gemcitabine Plus Surgery as Treatment for Relapsed and Refractory Non-Small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2026-12-01
Clinical trial
Cyclin D1 Based TPF(Docetaxel, Cisplatin and 5-fluorouracil) Induction Chemotherapy for OSCC(Oral Squamous Cell Carcinoma) Patients at cN2(Clinical Node 2) Stage: a Phase II Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Phase II Study ofFlu-Bu-Mel Conditioning Regimen for Patients With Myeloid Disease Undergoing Allogeneic Stem Cell TransplantationStatus: Completed, Estimated PCD: 2023-03-30
Clinical trial
A Phase I Study of Neoadjuvant Chemotherapy Involving Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Followed by Surgery for Patients With High Risk Localized Prostate CancerStatus: Recruiting, Estimated PCD: 2026-12-01
Clinical trial
A Phase I Multi-Center Study to Evaluate the Safety, Tolerability, and Efficacy of Chemotherapeutic Regiments in Surgical Patients With Infiltrating Ductal Carcinoma of BreastStatus: Recruiting, Estimated PCD: 2026-12-01
Clinical trial
An RCT Study to Investigate the Effect of Korean Red Ginseng for Middle-aged and Elderly Sub-health Population on Anti-oxidationStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Doxycycline-containing Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment: a Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-10
Clinical trial
Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast Cancer, an Open-labeled, Single Arm TrialStatus: Not yet recruiting, Estimated PCD: 2024-12-31
Clinical trial
Minocycline-containing Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment: a Real-world Evidence StudyStatus: Completed, Estimated PCD: 2024-03-30
Clinical trial
Evaluation of the Efficacy and Safety of Allogeneic Transplantation of Expanded Pancreatic Islet Cells in Patients With "Brittle" Type 1 DiabetesStatus: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Efficacy of Thalidomide for Refractory Small Intestinal Bleeding From Vascular MalformationStatus: Completed, Estimated PCD: 2020-12-01
Clinical trial
The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability of Patients With Grade 1 Hypertension Compared With Nitrendipine or Atenolol Monotherapy.Status: Recruiting, Estimated PCD: 2023-06-01
Clinical trial
Safety and Efficacy Evaluation of Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma (Non NPC): A Phase I TrialStatus: Completed, Estimated PCD: 2022-12-30
Clinical trial
Clinical Characteristics, Lifestyle and Integrated Microbiome, Metabolome, Transcriptome, Genome Analysis in Autoimmune GastritisStatus: Recruiting, Estimated PCD: 2023-07-01
Clinical trial
Short-course Trastuzumab, Pertuzumab Combined With Taxanes in the Adjuvant Treatment of Early Human Epidermal Growth Factor Receptor 2-positive Breast Cancer: an Open-label, Single-arm StudyStatus: Recruiting, Estimated PCD: 2026-12-01
Clinical trial
An Open, Dose-escalating Early Clinical Trial to Evaluate the Tolerability, Safety, and Efficacy of VGN-R09b by Intra Striatum Injection in Patients With Aromatic L-amino Acid Decarboxylase (AADC) Deficiency.Status: Recruiting, Estimated PCD: 2025-02-20
Clinical trial
A Randomized Phase II Trial of Low Stathmin Expression as a Predictive Biomarker for OSCC Patients Receiving TPF Induction Chemotherapy Followed by Radical Surgery and Radiotherapy/ChemoradiotherapyStatus: Recruiting, Estimated PCD: 2026-01-01
Clinical trial
GDF15 (Growth Differentiation Factor 15) Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at T3/T4cN0M0 Stage: a Phase II Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor (ARNI) With Amlodipine on Ventricular Remodeling in Hypertension and Left Ventricular Hypertrophy.Status: Recruiting, Estimated PCD: 2023-06-01
Clinical trial
ACEI/CCB Versus ACEI/DIU Combination Antihypertensive Therapy in Chinese Hypertensive Patients (ACvAD)Status: Completed, Estimated PCD: 2021-06-30
Clinical trial
Efficacy of Rectal Indomethacin in Prevention of Post-pancreatectomy Acute Pancreatitis-A Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2023-12-31
Clinical trial
A Randomized Phase II Trial of Limonene for Pulmonary Nodule ChemopreventionStatus: Recruiting, Estimated PCD: 2024-02-01
Clinical trial
Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation (IMPRESSION)Status: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic HypertensionStatus: Recruiting, Estimated PCD: 2024-12-31
Abstract
Anlotinib plus chemotherapy as first-line therapy for patients with gastrointestinal tumor with unresectable liver metastasis: Results from a multi-cohort, multicenter phase II trial (ALTER-G-001).Org: Ruijin Hospital, Shanghai Jiaotong University School, Shanghai, China, Shanghai Jiao Tong University School of Medicine, Jiading Central Hospital, Affiliated Hospital of Jiangnan University (Wuxi Fourth People's Hospital), Wuxi Branch of Ruijin Hospital,
Abstract
Integration analysis of single-cell multi-omics in the prostate cancer ecosystem.Org: Fudan University Shanghai Cancer Center, Shanghai Pudong New Area Gongli Hospital, Pediatric Translational Medicine Institute and Pediatric Congenital Heart Disease Institute, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine,
Clinical trial
A Prospective, Single-center, Open-arm, Single-arm Clinical Study to Evaluate the Safety and Efficacy of a Single Intravenous Infusion of LY-M001 Injection in Adolescents With Type I Gaucher DiseaseStatus: Recruiting, Estimated PCD: 2025-08-01